Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145

Tumor Biology

Volumn 37, Issue 2, 2016, Pages 1683-1691

  Lu, Hongzhi ^a   He, Yu ^b   Lin, Lin ^a   Qi, Zhengqin ^a   Ma, Li ^a   Li, Li ^a   Su, Ying ^a  

^a FIRST HOSPITAL OF QINHUANGDAO   (China)

^b Chengde Central Hospital   (China)

Author keywords

Cervical cancer; HPV; lncRNA; MALAT1; miR 145; Radiotherapy

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA 145; MALAT1 LONG NON-CODING RNA, HUMAN; MICRORNA; MIRN145 MICRORNA, HUMAN;

ADULT; APOPTOSIS; ARTICLE; ASSAY; CASKI CELL LINE; CELL CYCLE REGULATION; CERVICAL CANCER CELL LINE; CLINICAL ARTICLE; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE REPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IRRADIATION; MALAT1 GENE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RADIOSENSITIVITY; RNA BINDING PROTEIN IMMUNOPRECIPITATION; RNA PULL DOWN ASSAY; UPREGULATION; UTERINE CERVIX CANCER; WART VIRUS; COMPLICATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; RADIATION RESPONSE; RADIATION TOLERANCE; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; APOPTOSIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOPRECIPITATION; MICRORNAS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RADIATION TOLERANCE; RNA, LONG NONCODING; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84940061825     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3946-5     Document Type: Article

References (34)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: a Cancer Journal for Clinicians. 2014;64:9–29.
2. Rogers L, Siu SS, Luesley D, Bryant A, Dickinson HO. Radiotherapy and chemoradiation after surgery for early cervical cancer. The Cochrane Database of Systematic Reviews. 2012;5, CD007583.
3. Powell ME. Modern radiotherapy and cervical cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society. 2010;20:S49–51.
4. Munagala R, Kausar H, Munjal C, Gupta RC. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis. 2011;32:1697–705.
5. Lando M, Holden M, Bergersen LC, Svendsrud DH, Stokke T, Sundfor K, et al. Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer. PLoS Genetics. 2009;5, e1000719.
6. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Molecular Cancer. 2011;10:38.
7. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discovery. 2011;1:391–407.
8. Gibb EA, Becker-Santos DD, Enfield KS, Guillaud M, Niekerk D, Matisic JP, et al. Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasia. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society. 2012;22:1557–63.
9. Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH, Guo RH. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:4851–9.
10. Sun M, Xia R, Jin F, Xu T, Liu Z, De W, et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35:1065–73.
11. Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Molecular BioSystems. 2013;9:407–11.
12. Qin R, Chen Z, Ding Y, Hao J, Hu J, Guo F. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma. 2013;60:486–92.
13. Jiang Y, Li Y, Fang S, Jiang B, Qin C, Xie P, et al. The role of MALAT1 correlates with HPV in cervical cancer. Oncology Letters. 2014;7:2135–41.
14. Liu S, Song L, Zeng S, Zhang L. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2015.
15. Zhang J, Wang L, Li B, Huo M, Mu M, Liu J, et al. miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells. Experimental and Therapeutic Medicine. 2014;8:591–4.
16. Chang S, Gao L, Yang Y, Tong D, Guo B, Liu L, et al. miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells. Oncotarget. 2015;6:7675–85.
17. Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang Z, et al. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Letters. 2014;588:1168–77.
18. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, et al. National Comprehensive Cancer Network: cervical cancer. Journal of the National Comprehensive Cancer Network: JNCCN. 2013;11:320–43.
19. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Research. 2013;41:4976–87.
20. Zhang A, Zhou N, Huang J, Liu Q, Fukuda K, Ma D, et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Research. 2013;23:340–50.
21. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005;123:631–40.
22. Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, et al. A biochemical approach to identifying microRNA targets. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:19291–6.
23. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Research. 2013;73:1180–9.
24. Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z, et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. British Journal of Cancer. 2014;111:736–48.
25. Wang J, Su L, Chen X, Li P, Cai Q, Yu B, et al. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2014;68:557–64.
26. Yang F, Yi F, Han X, Du Q, Liang Z. MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Letters. 2013;587:3175–81.
27. Wang X, Li M, Wang Z, Han S, Tang X, Ge Y, et al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. The Journal of Biological Chemistry. 2015;290:3925–35.
28. Bandopadhyay M, Banerjee A, Sarkar N, Panigrahi R, Datta S, Pal A, et al. Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes. BMC Cancer. 2014;14:721.
29. Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q. LincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Molecular cancer research: MCR. 2015;13:330–8.
30. Shen H, Shen J, Wang L, Shi Z, Wang M, Jiang BH, et al. Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2015;69:301–5.
31. Chang, S., Gao, L., Yang, Y., Tong, D., Guo, B., Liu, L., Li, Z., Song, T., and Huang C. 2015. miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells. Oncotarget.
32. Xue G, Ren Z, Chen Y, Zhu J, Du Y, Pan D, et al. A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation. Cancer Letters. 2015;361:121–7.
33. Shi M, Du L, Liu D, Qian L, Hu M, Yu M, et al. Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells. The Journal of Pathology. 2012;228:148–57.
34. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384–8.